MedTrace Logo

Pelvic Drain After Rectal Resection for Mid-low Rectal Cancer

NCT04573621 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 518

Last updated 2020-10-05

No results posted yet for this study

Summary

This RCT aims at assessing the effects of a pelvic drain after total mesorectal excision for mid-low rectal cancer on the rates of pelvic sepsis and anastomotic leaks.

Conditions

Interventions

PROCEDURE

Pelvic drain

A pelvic drain is placed

OTHER

No pelvic drain is placed

A pelvic drain is not placed

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-31
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573621 on ClinicalTrials.gov